rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

InMode Ltd. -

INMD · Nasdaq

Health CareMedical DevicesSetting up

INMD stood above a rising 150-day average in 13 of the last 52 weekly readings, and has been out of that trend for the last 5 weeks. It is 2.4% below that average now. Medical Devices: 29% of its 181 stocks in an uptrend (−4 points in four weeks); Health Care: 28% (−6 points in four weeks).

Statistics

Rotation
Setting up
Weeks in an uptrend
out for 5
Industry in uptrend
29% -4 in 4 wk
Insider buys, 12 months
$0
Insider sales, 12 months
$0
Officials’ trades on record
3
Institutions holding
182 (+2)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 13 of 52 weeks.

22 Apr – 21 Oct
15%27%39%Apr 26Jun 26Jul 26Sep 26Oct 26

Medical Devices: A minority of its stocks are in an uptrend and the share has been slipping. Health Care: A minority of its stocks are in an uptrend and the share has been slipping.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$1$0$1Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

3 disclosed lines: House 3, Senate 0, executive 0; 1 people.

WhoDidAmountTraded
Tom Rice House: U.S. House ClerkSC07sold$1k–$15k24 Feb 2020filed 2 Mar 2020
Tom Rice House: U.S. House ClerkSC07sold$1k–$15k24 Feb 2020filed 2 Mar 2020
Tom Rice House: U.S. House ClerkSC07bought$1k–$15k15 Nov 2019filed 19 Nov 2019

Insiders

Buy orders, 12 months0
Sale orders, 12 months0
Buyers · sellers0 · 0

No open-market buy or sale by its insiders on record.

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders182+2 on the quarter
New · exited41 · 39
Reported value$415.2M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
Doma Perpetual Capital Management LLCreduced · filed 12 Aug 20262,730,931$39.9M-336,500−11.0%
BlackRock, Inc.added · filed 7 Aug 20262,495,402$36.5M+240,673+10.7%
RENAISSANCE TECHNOLOGIES LLCreduced · filed 13 Aug 20262,391,318$35.0M-194,900−7.5%
MENORA MIVTACHIM HOLDINGS LTD.unchanged · filed 13 Aug 20262,040,000$29.8M00.0%
STEEL PARTNERS HOLDINGS L.P.added · filed 7 Aug 20261,828,815$26.7M+33,454+1.9%
MILLENNIUM MANAGEMENT LLCadded · filed 14 Aug 20261,751,972$25.6M+590,192+50.8%
MORGAN STANLEYreduced · filed 13 Aug 20261,115,207$16.3M-208,576−15.8%
SYSTEMATIC FINANCIAL MANAGEMENT LPreduced · filed 14 Aug 20261,015,754$14.9M-138,703−12.0%
Jupiter Topco LLCnew · filed 14 Aug 2026966,020$14.1M+966,020
HOTCHKIS & WILEY CAPITAL MANAGEMENT LLCreduced · filed 14 Aug 2026739,260$10.8M-15,780−2.1%
31 Mar 2023 – 30 Jun 2026
180234288Mar 23Dec 23Dec 24Sep 25Jun 26

News

No headline names it lately.

Everyone who traded it

Moshe Itzkovich Company insiderChief Financial Officer · last 4 Aug 20260 · 0
Hadar Ron Company insiderDirector · last 30 Jul 20260 · 0
Nadav Kenneth Company insiderDirector · last 30 Jul 20260 · 0
Shlomo Nass Company insiderDirector · last 30 Jul 20260 · 0
Tom Rice HouseSC07 · last 24 Feb 20201 · 2

Same industry

RCEL Avita MedicalLeading+127%
HTFL HeartflowLeading+59%
ATRC AtriCureLeading+51%
HAE HaemoneticsLeading+44%
BVS BioventusLeading+24%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Profit per saleFY 2025 · to 31 Dec 202578.5%
Operating profit marginFY 2025 · to 31 Dec 202523.0%
Free cash flow marginFY 2025 · to 31 Dec 202522.7%
Return on capital employedFY 2025 · to 31 Dec 202512.3%
Research spendFY 2025 · to 31 Dec 20253.6%
Revenue growthFY 2025 · to 31 Dec 2025-6.2%
Earnings per share growthFY 2025 · to 31 Dec 2025-36.4%
Share count trendFY 2025 · to 31 Dec 2025-8.9%
Cash and equivalentsFY 2025 · to 31 Dec 2025$302.5M
Free cash flowFY 2025 · to 31 Dec 2025$84.3M

Analyst forecasts

No analyst forecasts yet.